MOUNTAIN VIEW, CA today announced that it has priced its public offering of 3,000,000 shares of its common stock. The offering was increased to 3,000,000 shares from 2,500,000 shares. Morgan Stanley & Co. Incorporated will be the sole underwriter for the offering.

The underwriter may offer the shares from time to time in one or more transactions in the over-the-counter market or through negotiated transactions at market prices or at negotiated prices. The offering is being made pursuant to a shelf registration statement that became effective on March 17, 2008.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state. A prospectus supplement relating to the offering will be filed with the Securities and Exchange Commission. When available, copies of the prospectus supplement and accompanying base prospectus may be obtained upon request to Morgan Stanley & Co. Incorporated, 180 Varick Street, New York, New York 10014, Attention Prospectus Department (telephone: 866.718.1649), or by e-mail at prospectus@morganstanley.com.

About Hansen Medical

Hansen Medical, based in Mountain View, Calif., was founded in 2002 to develop products and technology using robotics for the accurate positioning, manipulation and stable control of catheters and catheter-based technologies. The Sensei Robotic Catheter System(TM) and Artisan Control Catheter(TM) are cleared by the FDA to guide pre-approved percutaneous catheters for mapping anatomy of the heart. Additional information can be found at www.hansenmedical.com. Hansen Medical has pending trademark applications for "Hansen Medical," "Sensei," "Artisan," "Hansen Artisan," as well as the Hansen Medical "heart design" logo. Hansen Medical, Hansen Medical Heart Design logo, Sensei, Artisan, Instinctive Motion, IntelliSense, and Fine Force Technology are trademarks of Hansen Medical, Inc. in the United States and other countries. All trademarks and registered trademarks are property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. These statements are based on the current estimates and assumptions of our management as of the date of this press release and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause actual results to differ materially from those indicated by forward-looking statements. Factors that might cause such differences include those described in under the heading "Risk Factors" contained in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2007 filed with the Securities and Exchange Commission (SEC) on February 28, 2008 and the risks discussed in our other filings with the SEC. We undertake no obligation to revise or update information the forward-looking information contained in this press release.

Investor Contact: Steven Van Dick 650.404.5800 Email Contact Lasse Glassen Financial Relations Board 213.486.6546 Email Contact Media Contact: Amy Cook 925.552.7893 Email Contact

Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.